Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
-
Pol. Merkur. Lekarski · Sep 2010
Randomized Controlled Trial Comparative Study[Influence of low-molecular-weight heparin on the life quality of patients after intravascular medical procedures in comparison to patients who were treated with oral anticoagulants].
Atherosclerosis is the illness of arteries which causes changes in vessels leading to their narrowing and then to their closure. Men are mainly attacked by illnesses of arteries. There are several factors which can intensify these illnesses such as: diabetes, smoking cigarettes, diet rich in cholesterol, arterial hypertension. Chronic ischemia of lower extremities is the most frequent illness with which patients notify. Patients with long-standing atherosclerotic process are usually afflicted with thrombotic ischemia. The life quality is the term that can have many meanings. It can be treated objectively or subjectively. In the first case we deal with the quality of life and in the second one with the feeling of life quality. Considering the problem we can base on the level of fulfilling the norm or on riches of obtained experience. The term life quality is significantly connected with the process of cognitive assessment of the individual. The quality of life of patients who were subjected to intravascular medical procedures considerably changes. The continuation of surgical treatment is pharmacotherapy which is connected with administering to patients low-molecular-weight heparin or oral antithrombotic medicine. The aim of the study was an evaluation of quality of life of patient after intravascular medical procedures, at which continued treatment was low-molecular-weight heparin and comparison of received results with subjective feeling of quality of life among ill across passing, treated oral anticoagulants medicines. ⋯ Conducted research has shown that the life quality of patients who were treated with low-molecular-weight heparin changed for better in higher degree than patients who were treated with oral antithrombotic medicine.